Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

165.02 +1.53 (+0.94%)
Official Closing Price Updated: 7:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
3 Ways to Play the Ongoing Demand for Farmland
If you’re considering investing in farmland, there are several ways to do so without owning the land directly. 
Via InvestorPlace
Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
Via Benzinga
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
From Zoetis Inc.
Via Business Wire
Zoetis's Return On Capital Employed Overview
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally 
Via MarketBeat
Zoetis Declares Third Quarter 2023 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis' Osteoarthritis Med for Dogs Set to Deliver Significant Advantages In 2024, Analyst Says
Friday, the FDA approved Zoetis Inc's (NYSE: ZTS) Librela (bedinvetmab) for the control of pain associated with  
Via Benzinga
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
Zoetis (ZTS) Q1 2023 Earnings Call Transcript
ZTS earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Zoetis Tumbles As Spot's Drugmaker Reports Mixed Earnings, Though Keeps Outlook
Zoetis says it still expects sales and earnings to grow in 2023. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Zoetis Announces First Quarter 2023 Results
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. 
Via Benzinga
$1000 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Zoetis Announces Date for 2023 Investor Day
From Zoetis Inc.
Via Business Wire
5 Women-Led Businesses Absolutely Crushing the Stock Market Right Now
The number of businesses led by women is growing every year. And as the results show, investors should embrace -- and invest in -- women-led companies. 
Via The Motley Fool
Why These 2 Vet Med Stocks Are Surging
The boom in pet adoptions during the pandemic will pay off for years for these companies. 
Via The Motley Fool
3 Pet Stocks That Could Purr in 2023 and Beyond
These three pet stocks are all worth a look, particularly by long-term investors seeking a sector with impressive growth catalysts. 
Via InvestorPlace
This Favorable Sign Appears On Zoetis's Chart
Via Benzinga
Zoetis Stock Shows Healthy Growth Along With Puppies, Kittens
Zoetis stock is trying to complete a flat base with a 176.76 buy point. See if it can break out. Its stock got an upgrade Monday 
Via Investor's Business Daily
Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being
From Zoetis Inc.
Via Business Wire
3 Healthcare Stocks to Watch As the Industry Evolves
Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services. 
Via InvestorPlace
Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results
From Zoetis Inc.
Via Business Wire
Zoetis Stock Sees IBD Relative Strength Rating Improve To 73
Zoetis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the 80-plus score you look for. 
Via Investor's Business Daily
Zoetis Named One of the World’s Most Ethical Companies by Ethisphere
From Zoetis Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.